Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: The effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study

Journal of Photochemistry and Photobiology B: Biology

Volumn 80, Issue 1, 2005, Pages 19-27

  Pegaz, Bernadette ^a   Debefve, Elodie ^a   Borle, Francois ^a   Ballini, Jean Pierre ^a   van den Bergh, Hubert ^a   Kouakou Konan, Yvette Niamien ^a  

^a EPFL   (Switzerland)

Author keywords

CAM model; Chick embryo; Chlorins; Extravasation; Lipophilicity; Nanoparticles; Photodynamic therapy; Photosensitizer; Porphyrins; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CHLORIN DERIVATIVE; CHLORIN E6; NANOPARTICLE; PHEOPHORBIDE; PHEOPHORBIDE A; PHOTOSENSITIZING AGENT; POLYLACTIC ACID; PORPHYRIN DERIVATIVE; PORPHYRINS AND PORPHYRIN DERIVATIVES; TETRAKIS(4 CARBOXYPHENYL)PORPHYRIN; TETRAKISPHENYLPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABLE IMPLANT; BLOOD VESSEL INJURY; CALCULATION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXTRAVASATION; EMBRYO; FLUORESCENCE ANGIOGRAPHY; IN VIVO STUDY; LIPOPHILICITY; MICROENCAPSULATION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK BENEFIT ANALYSIS; SUBRETINAL NEOVASCULARIZATION; THROMBOGENESIS;

ALLANTOIS; ANIMALS; CAPSULES; CHICK EMBRYO; CHORION; COLORING AGENTS; EMULSIONS; FREEZE DRYING; KINETICS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SPECTROMETRY, FLUORESCENCE;

EID: 20444503953     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2005.02.003     Document Type: Article

References (26)

1. N.M. Bressler S.B. Bressler S.L. Fine Age-related macular degeneration Surv. Ophthalmol. 32 6 1988 375-413
2. M. Sickenberg Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: From clinical trials to clinical practice Semin. Ophthalmol. 16 4 2001 207-212
3. H. van den Bergh J.-P. Ballini M. Sickenberg Photodynamic therapy for subfoveal choroidal neovascularisation in various diseases among which age-related macular degeneration: An update Med. Laser Appl. 18 1 2003 65-78
4. T.A. Ciulla R.P. Danis A. Harris Age-related macular degeneration: A review of experimental treatments Surv. Ophthalmol. 43 2 1998 134-146
5. N.M. Bressler Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2 Am. J. Ophthalmol. 133 1 2002 168-179
6. U. Schmidt-Erfurth T. Hasan Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration Surv. Ophthalmol. 45 3 2000 195-214
7. U. Schmidt-Erfurth et al. Photodynamic effects on choroidal neovascularization and physiological choroid Invest. Ophthalmol. Vis. Sci. 43 3 2002 830-841
8. R.Z. Renno J.W. Miller Photosensitizer delivery for photodynamic therapy of choroidal neovascularization Adv. Drug Deliv. Rev. 52 1 2001 63-78
9. Y. Kawashima Nanoparticulate systems for improved drug delivery Adv. Drug Deliv. Rev. 47 1 2001 1-2
10. E. Allemann et al. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles Int. J. Cancer 66 6 1996 821-824
11. Y.N. Konan et al. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles Eur. J. Pharm. Sci. 18 3-4 2003 241-249
12. Y.N. Konan R. Gurny E. Allemann State of the art in the delivery of photosensitizers for photodynamic therapy J. Photochem. Photobiol. B: Biol. 66 2 2002 89-106
13. A. Vargas et al. Improved photodynamic activity of porphyrin loaded into nanoparticles: An in vivo evaluation using chick embryos Int. J. Pharm. 286 1-2 2004 131-145
14. L. Nobs et al. Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods Int. J. Pharm. 250 2 2003 327-337
15. Y.N. Konan et al. Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy Eur. J. Pharm. Biopharm. 55 1 2003 115-124
16. Y.N. Konan R. Gurny E. Allemann Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles Int. J. Pharm. 233 1-2 2002 239-252
17. D. Quintanar-Guerrero et al. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers Drug Dev. Ind. Pharm. 24 12 1998 1113-1128
18. N. Lange et al. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV Invest. Ophthalmol. Vis. Sci. 42 1 2001 38-46
19. A.L. Romanoff Biochemistry of the Avian Embryo: A Quantitative Analysis of Prenetal Development 1967 Wiley New York 398
20. V. Gottfried et al. In vivo damage to chorioallantoic membrane blood vessels by porphycene-induced photodynamic therapy J. Photochem. Photobiol. B: Biol. 30 2-3 1995 115-121
21. M.J. Hammer-Wilson et al. Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers J. Photochem. Photobiol. B: Biol. 53 1-3 1999 44-52
22. E. Allemann R. Gurny E. Doelker Preparation of aqueous polymeric nanodispersions by a reversible salting-out process - influence of process parameters on particle-size Int. J. Pharm. 87 1-3 1992 247-253
23. A. Gopferich Mechanisms of polymer degradation and erosion Biomaterials 17 2 1996 103-114
24. R. Bachor et al. Mechanism of photosensitization by microsphere-bound chlorin e6 in human bladder carcinoma cells Cancer Res. 51 16 1991 4410-4414
25. Y.N. Konan et al. Encapsulation of p-THPP into nanoparticles: Cellular uptake, subcellular localization and effect of serum on photodynamic activity Photochem. Photobiol. 77 6 2003 638-644
26. Y. Takakura R.I. Mahato M. Hashida Extravasation of macromolecules Adv. Drug Deliv. Rev. 34 1 1998 93-108